Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - ImmunityBio, Inc. | nk-10q_20180630.htm |
| EX-32.1 - EX-32.1 - ImmunityBio, Inc. | nk-ex321_7.htm |
| EX-31.2 - EX-31.2 - ImmunityBio, Inc. | nk-ex312_8.htm |
| EX-31.1 - EX-31.1 - ImmunityBio, Inc. | nk-ex311_9.htm |
| EX-10.2 - EX-10.2 - ImmunityBio, Inc. | nk-ex102_65.htm |
| EX-10.1 - EX-10.1 - ImmunityBio, Inc. | nk-ex101_64.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Sonja Nelson, the chief financial officer of NantKwest, Inc. (the “Company”), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
|
i. |
the Quarterly Report of the Company on Form 10-Q for the quarter ended June 30, 2018 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
ii. |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: August 6, 2018 |
By: |
|
/s/ Sonja Nelson |
|
|
|
|
Sonja Nelson |
|
|
|
|
Chief Financial Officer (Principal Financial Officer) |